{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:28:09Z","timestamp":1790483289158,"version":"4.1.0"},"reference-count":66,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"AbbVie Global"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2016,10,2]]},"DOI":"10.1080\/13696998.2016.1189920","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T10:28:50Z","timestamp":1463048930000},"page":"983-994","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Economic evaluation of ombitasvir\/paritaprevir\/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection"],"prefix":"10.1080","volume":"19","author":[{"given":"Scott J.","family":"Johnson","sequence":"first","affiliation":[{"name":"Medicus Economics Inc., Milton, MA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Paris\u00e9","sequence":"additional","affiliation":[{"name":"Medicus Economics Inc., Milton, MA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchin","family":"Virabhak","sequence":"additional","affiliation":[{"name":"Medicus Economics Inc., Milton, MA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Filipovic","sequence":"additional","affiliation":[{"name":"AbbVie UK, Maidenhead, Berkshire, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Samp","sequence":"additional","affiliation":[{"name":"AbbVie Global, Mettawa, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Misurski","sequence":"additional","affiliation":[{"name":"AbbVie Global, Mettawa, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckr083"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12247"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2010.03.018"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.07.033"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01927.x"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000181"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.0096"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.964720"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2013.19.6.438"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta15170"},{"key":"e_1_3_5_12_1","doi-asserted-by":"crossref","first-page":"19562","DOI":"10.2807\/ese.15.18.19562-en","article-title":"The growing contribution of hepatitis C virus infection to liver-related mortality in Scotland.","volume":"15","author":"McDonald SA","year":"2010","unstructured":"McDonald SA, Hutchinson SJ, Bird SM, et\u00a0al. The growing contribution of hepatitis C virus infection to liver-related mortality in Scotland. Euro Surveill 2010;15:19562","journal-title":"Euro Surveill"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.113217"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604563"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32832ff35d"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.11.003"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-16"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir076"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.038257"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i18.2793"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835eb8bf"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12273"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta8390"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.8156"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1934"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcu202"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12715"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-015-0443-3"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"e_1_3_5_30_1","unstructured":"American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (ISDA). Recommendations for testing managing and treating hepatitis C [Internet]. 2016. http:\/\/www.hcvguidelines.org. Accessed April 19 2016"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402338"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402869"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401561"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.045"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11110"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462309090229"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199906)58:2<127::AID-JMV5>3.0.CO;2-K"},{"key":"e_1_3_5_39_1","unstructured":"National Institute for Health and Care Excellence (NICE). Simeprevir for the treatment of genotype 1 and genotype 4 chronic hepatitis C [Single Technology Appraisal ID668] 18 September 2014. https:\/\/www.nice.org.uk\/guidance\/TA331\/documents\/hepatitis-c-chronic-simeprevir-id668-evaluation-report2. Last accessed May 18 2016"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta10210"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.064774"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.028"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9024300"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00001"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12132"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7106.453"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012912"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013086"},{"key":"e_1_3_5_51_1","unstructured":"Monthly Index of Medical Specialties (MIMS) [Internet]. Available at http:\/\/www.mims.co.uk\/. Last accessed May 24 2014"},{"key":"e_1_3_5_52_1","unstructured":"Curtis L. Unit costs of health and social care. Personal Social Services Research Unit 2013"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S37205"},{"key":"e_1_3_5_54_1","unstructured":"National Institute for Health and Care Excellence (NICE). Sofosbuvir for chronic hepatitis C 18 March 2014. https:\/\/www.nice.org.uk\/guidance\/TA330\/documents\/hepatitis-c-chronic-sofosbuvir-evaluation-report4. Last accessed May 18 2016"},{"key":"e_1_3_5_55_1","volume-title":"Clinical Practice Guideline","author":"National Institute for Health and Care Excellence (NICE)","year":"2010","unstructured":"National Institute for Health and Care Excellence (NICE). Depression: the treatment and management of depression in adults (updated edition). Clinical Practice Guideline 90. British Psychological Society, Leicester, UK and the Royal College of Psychiatrists, London, UK, 2010"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.006"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22375"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27831"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1176030"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-015-0320-4"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12871"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27010"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2014.906307"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.09.025"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126984"},{"key":"e_1_3_5_66_1","volume-title":"England Clinical Reference Group for Infectious Diseases. Clinical commissioning policy statement: treatment of chronic hepatitis C in patients with cirrhosis [Internet]","author":"National Health Service (NHS)","year":"2015","unstructured":"National Health Service (NHS) England Clinical Reference Group for Infectious Diseases. Clinical commissioning policy statement: treatment of chronic hepatitis C in patients with cirrhosis [Internet]. National Health Services, 2015. Presented at HepDART 2011, Kauai, HI, USA, December 4\u20138. http:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2015\/06\/hep-c-cirrhosis-polcy-statmnt-0615.pdf. Accessed October 6, 2015"},{"key":"e_1_3_5_67_1","volume-title":"Review activity\/safety: telaprevir in combination with peginterferon alfa-2a and ribavirin increased sustained virologic response in genotype 1 chronic HCV","author":"Kauffman RS","year":"2011","unstructured":"Kauffman RS, Muir AJ, Nelson DR, et\u00a0al. Review activity\/safety: telaprevir in combination with peginterferon alfa-2a and ribavirin increased sustained virologic response in genotype 1 chronic HCV. Conference reports for the National AIDS Treatment Advocacy Project. 2011. Presented at HepDART 2011, Kauai, HI, USA, December 4\u20138. http:\/\/www.natap.org\/2011\/hepDART\/hepDART_03.htm. Accessed October 6, 2015"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2016.1189920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:10:52Z","timestamp":1770930652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2016.1189920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,30]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10,2]]}},"alternative-id":["10.1080\/13696998.2016.1189920"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2016.1189920","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}